Crispr Therapeutics AG (CRSP) Stock Price Today
Aura AI Summary
Key Stats
- $3.92BMarket Cap
- 2,388,717Volume
- HealthSector
- $61.8952W High
- $40.3752W Low
- 79 DaysTypical Hold Time
- $2.42BEnterprise Value
- -Div Yield
- 34% Sell | 66% BuyTrading Activity
Track Crispr Therapeutics AG (CRSP) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Crispr Therapeutics AG has traded between a low of $40.28 and a high of $61.89, highlighting its annual price range. Buy and sell Crispr Therapeutics AG shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Crispr Therapeutics AG
CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, CTX001, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.
Most Recent News
Microsoft expands use of Haivision tech for live production of 600+ global events annually
Microsoft has expanded its partnership with Haivision by adopting the Makito ONE video transport platform, Makito X4 video encoders and decoders, Haivision Pro mobile transmitters, and Haivision Hub 360 for live production of over 600 global events e...

Piper Sandler upgrades Medtronic on growth from acquisitions and new treatments.
Piper Sandler upgraded Medtronic to Overweight with a $120 price target, citing strategic growth through acquisitions and product launches in vascular, heart rhythm, and robotic surgery. Medtronic's recent acquisition of Contego Medical expands its c...

Malaysia's e-commerce market to nearly double to $25.65B by 2032, driven by mobile shopping and digital payments.
Malaysia's e-commerce market is projected to grow from $13.85 billion in 2027 to $25.65 billion by 2032, with a CAGR of 13.12%. Growth is fueled by increased smartphone use, digital wallet adoption, expanding logistics, and social commerce. B2C remai...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.